NERA Senior Consultant Dr. Gabriella Monahova will speak during an ABA hosted teleconference titled, “Sabre/Farelogix – Litigating a Killer Acquisition.”
Dr. Monahova and fellow panelists will address a range of questions in relation to the case, including:
- How should we assess whether an acquisition of a nascent competitor is anticompetitive?
- What tools and metrics should the agencies and courts use to determine the likely competitive effects of an acquisition of a nascent competitor, given we have no crystal ball and those effects may be speculative or far in the future?
- How might the Sabre/Farelogix case shape future “killer acquisition” reviews?
